Skip to content

To study the efficacy of homoeopathy in management of rheumatoid arthritis

A comparative study to assess the effectiveness of individualised homoeopathic medicines with standard line of treatment in the improvement of disease activity score in management of rheumatoid arthritis: a randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101901
Enrollment
200
Registered
2026-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

Intervention1: Individualised Homoeopathic Medicines: Individualised Homoeopathic Medicines will be administered to 100 Patients (Group A) of Rheumatoid Arthritis as intervention and effect will be co

Sponsors

Dr Preeti Lamba
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants must be diagnosed with rheumatoid arthritis according to recognised diagnostic standards set by American College of Rheumatology/European League Against Rheumatism Both male and female 2. Age 30 to 50 years 3. Disease Activity Score 28 between 2.6 to 5.1

Exclusion criteria

Exclusion criteria: 1. Age less than 30 and above 50 years 2. Disease Activity Score 28 less than 2.6 and more than 5.1 3. Any bone deformity 4. Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
To assess the extent of reduction in joint pain, swelling and stiffness measured by the Disease Activity Score (DAS28) in Rheumatoid Arthritis patientsTimepoint: Every three months

Secondary

MeasureTime frame
To assess improvement in health-related quality of life measured by the Health Assessment Questionnaire in Rheumatoid Arthritis patientsTimepoint: Every three months;To measure the improvement or changes if any in necessary investigations performed at the beginning and end of study especially C- Reactive Protein (CRP) & Erythrocyte Sedimentation Rate (ESR)Timepoint: Every three months

Countries

India

Contacts

Public ContactDr Preeti Lamba

Dr D Y Patil Homoeopathic Medical College and Research Centre Pimpri Pune

principal.homoeopathy@dpu.edu.in9422330045

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026